Latest news
Oculis Holding AG Stock 12‑Month Price Target Cut to $36.26, Implies 193% Upside - TradingViewTradingView · Fri, 07 Aug 2026 06:20:00 GMTOculis Holding AG reports results for the quarter ended June 30 - Earnings Summary - TradingViewTradingView · Fri, 07 Aug 2026 01:55:00 GMTOCS: Privosegtor and Licaminlimab trials advance, with strong cash reserves supporting long-term growth - TradingViewTradingView · Thu, 06 Aug 2026 20:35:35 GMTOCS Q2'26 Earnings: revenue estimate is 233.98K USD - TradingViewTradingView · Thu, 30 Jul 2026 07:00:00 GMTOculis Holding AG Revenue Breakdown – NASDAQ:OCSAW - TradingViewTradingView · Wed, 29 Jul 2026 15:38:06 GMT